NCT00943722 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 648
- group Id
- BG001
- value
- 643
- group Id
- BG002
- value
- 644
- group Id
- BG003
- value
- 669
- group Id
- BG004
- value
- 470
- group Id
- BG005
- value
- 3074
- units
- Participants
- groups
- description
- 9-valent human papillomavirus (9vHPV) L1 virus-like particle (VLP) vaccine, 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6. Vaccine dose administered was obtained from manufacturing Lot 1.
- id
- BG000
- title
- Base Study: 9- to 15-Year-Old Females (Lot 1)
- description
- 9vHPV L1 VLP vaccine, 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6. Vaccine dose administered was obtained from manufacturing Lot 2.
- id
- BG001
- title
- Base Study: 9- to 15-Year-Old Females (Lot 2)
- description
- 9vHPV L1 VLP vaccine, 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6. Vaccine dose administered was obtained from manufacturing Lot 3.
- id
- BG002
- title
- Base Study: 9- to 15-Year-Old Females (Lot 3)
- description
- 9vHPV L1 VLP vaccine, 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6. Vaccine dose administered was obtained from manufacturing Lot 1.
- id
- BG003
- title
- Base Study: 9- to 15-Year-Old Males (Lot 1)
- description
- 9vHPV L1 VLP vaccine, 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6. Vaccine dose administered was obtained from manufacturing Lot 1.
- id
- BG004
- title
- Base Study: 16- to 26-Year-Old Females (Lot 1)
- description
- Total of all reporting groups
- id
- BG005
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 440
- group Id
- BG001
- value
- 432
- group Id
- BG002
- value
- 432
- group Id
- BG003
- value
- 450
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1754
- title
- 9 to 12 years
- categories
- measurements
- group Id
- BG000
- value
- 208
- group Id
- BG001
- value
- 211
- group Id
- BG002
- value
- 212
- group Id
- BG003
- value
- 219
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 850
- title
- 13 to 15 years
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 470
- group Id
- BG005
- value
- 470
- title
- 16 to 26 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 648
- group Id
- BG001
- value
- 643
- group Id
- BG002
- value
- 644
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 470
- group Id
- BG005
- value
- 2405
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 669
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 669
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- population Description
- Per protocol, baseline characteristics were analyzed in all participants randomized in the base study.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 648
- group Id
- BG001
- value
- 643
- group Id
- BG002
- value
- 644
- group Id
- BG003
- value
- 669
- group Id
- BG004
- value
- 470
- group Id
- BG005
- value
- 3074
- units
- Participants
- groups
- description
- 9-valent human papillomavirus (9vHPV) L1 virus-like particle (VLP) vaccine, 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6. Vaccine dose administered was obtained from manufacturing Lot 1.
- id
- BG000
- title
- Base Study: 9- to 15-Year-Old Females (Lot 1)
- description
- 9vHPV L1 VLP vaccine, 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6. Vaccine dose administered was obtained from manufacturing Lot 2.
- id
- BG001
- title
- Base Study: 9- to 15-Year-Old Females (Lot 2)
- description
- 9vHPV L1 VLP vaccine, 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6. Vaccine dose administered was obtained from manufacturing Lot 3.
- id
- BG002
- title
- Base Study: 9- to 15-Year-Old Females (Lot 3)
- description
- 9vHPV L1 VLP vaccine, 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6. Vaccine dose administered was obtained from manufacturing Lot 1.
- id
- BG003
- title
- Base Study: 9- to 15-Year-Old Males (Lot 1)
- description
- 9vHPV L1 VLP vaccine, 0.5 mL intramuscular injection at Day 1, Month 2, and Month 6. Vaccine dose administered was obtained from manufacturing Lot 1.
- id
- BG004
- title
- Base Study: 16- to 26-Year-Old Females (Lot 1)
- description
- Total of all reporting groups
- id
- BG005
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 440
- group Id
- BG001
- value
- 432
- group Id
- BG002
- value
- 432
- group Id
- BG003
- value
- 450
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1754
- title
- 9 to 12 years
- categories
- measurements
- group Id
- BG000
- value
- 208
- group Id
- BG001
- value
- 211
- group Id
- BG002
- value
- 212
- group Id
- BG003
- value
- 219
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 850
- title
- 13 to 15 years
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 470
- group Id
- BG005
- value
- 470
- title
- 16 to 26 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 648
- group Id
- BG001
- value
- 643
- group Id
- BG002
- value
- 644
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 470
- group Id
- BG005
- value
- 2405
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 669
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 669
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- population Description
- Per protocol, baseline characteristics were analyzed in all participants randomized in the base study.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle